INTERnational Cooperation of high containment

research infrastructures: from Epidemic
Preparedness TO Response (INTERCEPTOR)

As INTERCEPTOR approaches the end of its current funding period, discover how the project has strengthened international cooperation in high-containment research. Coordinated by ERINHA and funded by the European Union through Horizon Europe, INTERCEPTOR brought together partners to share expertise, develop training tools and lay the foundations for lasting collaboration. Watch our video to explore…

How can European research infrastructures work together to strengthen preparedness for future health emergencies? On 5 November 2026, INTERCEPTOR, EVORA and ISIDORe will bring together researchers, policymakers and international partners for a hybrid event in Brussels. Registration is open for online participation. Entitled “From European Preparedness to Global Resilience: The Strategic Role of European Research…

Representatives from three INTERCEPTOR partner institutions recently met to harmonise their practices and reinforce collaboration within the project. Held last February, the meeting focused on aligning ex vivo approaches used to study high-risk pathogen infections and to test medical countermeasures, while ensuring compliance with the 3Rs principles (Replacement, Reduction and Refinement). Participants engaged in constructive…

The EU-funded INTERCEPTOR network is expanding its international reach with five new Associated Partners across Asia, Europe and Latin America, strengthening global collaboration in high-containment research and pandemic preparedness. This expansion reinforces cooperation between leading research infrastructures and enhances the global capacity to respond to emerging and re-emerging infectious diseases. The new partners bring cutting-edge…

The INTERCEPTOR Project 2026 Annual Meeting in Paris brought together partners from across the consortium to review progress and align on next steps. The positive atmosphere captured in this group photo reflects the strong collaboration and commitment driving the project forward. We are proud of the work accomplished so far and look forward to continuing…

Understanding how we prepare for emerging infectious threats is key to protecting public health. This short video presents the INTERCEPTOR project, its objectives, and the collaborative efforts behind it. 🎬 In less than two minutes, discover how the project contributes to advancing research and strengthening global preparedness.

Paving the way for the next stage. As of January 2026, INTERCEPTOR has entered its final year of implementation. Key priorities for this phase include: With strengthened international partnerships, harmonised training frameworks, and a growing global HCL network, INTERCEPTOR is consolidating its legacy as a sustainable platform for global high-containment cooperation.

Towards a Common Service Catalogue for High-Containment Research. INTERCEPTOR is developing a structured service catalogue to enhance access to high-containment laboratory capabilities across its network. A dedicated questionnaire was launched to map services in: In parallel, international high-containment laboratories outside the consortium are being mapped to identify complementary expertise and potential collaboration opportunities. The future…

Mapping Global HCL Capacities: Inventory and Gap Analysis Launched. To strengthen interoperability and identify strategic gaps in high-containment laboratory capabilities, INTERCEPTOR launched the “Interceptor Inventory and Gap Analysis for HCL 2025” survey in May 2025. The survey consolidates collaborative work conducted across partner institutions and aims to: The results will serve as a foundation for…

Strengthening Biorisk Management Through ISO 35001 Training. A major focus of INTERCEPTOR’s Work Package 2 is the harmonisation of biorisk management practices across high-containment laboratories. In this context, a dedicated ISO 35001:2019 training programme has been developed, including: These tools aim to support laboratories in implementing or improving compliance with the international biorisk management standard.…